secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2022-05-06T23:59:59+00:00
Accession:  0001193125-22-142536
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health director Bahija Jallal to resign at June 2022 annual meeting
----------------------------------------------------------------------------

- Dr. Bahija Jallal notified Board on May 4, 2022 of her resignation as director, effective June 15, 2022 Annual Meeting.
- Resignation is not due to any dispute or disagreement with the company on operations, policies, or practices.
- No replacement director announced in the filing; board composition will change effective June 15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312522142536/0001193125-22-142536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312522142536/d345130d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-142536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer